Autoimmune Life Blog

BRI’s newest principal investigator, Carmen Mikacenic, MD, is used to working with dangerous pathogens. Still, when she started studying aspects of COVID-19, she took extra precautions.

One goal is to find markers that identify why some people with the virus don’t have symptoms while others get fatally ill. The sickest patients tend to have multiple health issues, which makes it hard to pinpoint the factors related to COVID-19.

COVID-19 has put a therapy called hydroxychloroquine in the spotlight — and, at the same time, shrouded it in confusion.

With a newly awarded $4 million grant from The Leona M. and Harry B. Helmsley Charitable Trust, BRI and SCRI will now focus on using their novel approach to generate an engineered T cell product that can be used in a future first-in-human clinical trial.

In the face of COVID-19, the Brooke family got used to things being canceled: school and work now happen at their home in Portland, Oregon. Twins Zoe and Andrew had to change their plans for their 10th birthday party.

Even before the governor closed the schools, I think we realized COVID-19 was going to be a really big deal. Still, for many of us, that was the day it hit home. The virus was going to alter the way we live, work, learn and connect with others - maybe for years to come.

In February, Dana VanBuecken, ARNP, was living her normal life as a clinical research nurse and mother of four who lives with type 1 diabetes (T1D).

We recently kicked off a potentially game-changing partnership with the new Allen Institute for Immunology. Fueled by a $125 million gift from the late Paul G. Allen, this partnership aims to learn more about how the immune system works from health to disease.

When some people are diagnosed with type 1 diabetes (T1D), the disease progresses so quickly that their pancreas stops making insulin within a year.  For others, the process is slower and this can make their T1D easier to manage.  But what if we could identify these fast progressors early, and ma

BRI is inviting Seattle-area adults to participate in the Sound Life Project, a groundbreaking research study to build a baseline of knowledge over time about the human immune system to better understand disease.